Is elimination of HCV in 2030 realistic in Central Europe.
epidemiology
hepatitis C virus
liver
therapy
Journal
Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
22
02
2021
accepted:
22
02
2021
entrez:
22
6
2021
pubmed:
23
6
2021
medline:
29
6
2021
Statut:
ppublish
Résumé
According to the recent data presented by Central-European HCV experts, the estimated prevalence of HCV is between 0.2% and 1.7% in certain countries in this region. There are no financial limitations to access to treatment in most countries. Patients in these countries have access to at least one pangenotypic regimen. The most common barriers to the elimination of HCV in Central Europe are a lack of established national screening programmes and limited political commitment to the elimination of HCV. Covid-19 has significantly affected the number of patients who have been diagnosed and treated, thus, delaying the potential elimination of HCV. These data suggest that the elimination of HCV elimination projected by WHO before 2030 will not be possible in the Central Europe.
Substances chimiques
Antiviral Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
56-60Informations de copyright
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
WHO. Global hepatitis report, 2017. Geneva, Switzerland: World Health Organization. http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf
Marshall AD, Cunningham EB, Nielsen S, et al. Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe. Lancet Gastroenterol Hepatol. 2018;3(2):125-133.
Cooke GS, Andrieux-Meyer I, Applegate TL, et al. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2019;4(2):135-184.
WHO. Global health sector strategy on viral hepatitis 2016-2021. Geneva, Switzerland: World Health Organization. http://apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pdf
Razavi H, Gonzalez YS, Pangerl A, et al. Global timing of hepatitis C virus elimination: estimating the year countries will achieve the World Health Organization elimination targets. J Hepatol. 2019;70(1 suppl. 1):E748 (SAT-260).
Flisiak R, Frankova S, Grgurevic I, et al. How close are we to hepatitis C virus elimination in Central Europe? Clin Exp Hepatol. 2020;6(1):1-8.
Blach S, Kondili LA, Aghemo A, et al. Impact of COVID-19 on global hepatitis C elimination efforts [published online ahead of print, 2020 Aug 7]. J Hepatol. 2020;S0168-8278(20)30523-7.